dexrazoxane has been researched along with Hematologic Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Badalamenti, G; Improta, L; Mazzocca, A; Napolitano, A; Santini, D; Silletta, M; Spalato Ceruso, M; Tonini, G; Valeri, S; Vincenzi, B | 1 |
1 other study(ies) available for dexrazoxane and Hematologic Diseases
| Article | Year |
|---|---|
Use of Cardioprotective Dexrazoxane Is Associated with Increased Myelotoxicity in Anthracycline-Treated Soft-Tissue Sarcoma Patients.
Topics: Adult; Aged; Anthracyclines; Antibiotics, Antineoplastic; Dexrazoxane; Female; Hematologic Diseases; Humans; Male; Middle Aged; Neutropenia; Protective Agents; Retrospective Studies; Sarcoma; Young Adult | 2019 |